Mouthwash may tame cancer Drug's side effect
NCT ID NCT06974604
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 36 times
Summary
This study tests whether a steroid mouthwash (dexamethasone) can reduce painful mouth sores caused by the cancer drug datopotamab deruxtecan. About 60 adults with advanced breast or lung cancer will use the mouthwash four times a day for the first few treatment cycles. The goal is to lower the rate of mouth sores by 20% and improve quality of life during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORMONE RECEPTOR-POSITIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rhode Island and the Miriam Hospitals (Brown University Health)
RECRUITINGProvidence, Rhode Island, 02903/02906, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.